Skip to main content
  • First self testing Rapid test for COVID-19 approved by ICMR

    Mylab Discovery Solutions announced the first self use Rapid test of India, Coviself which is approved by ICMR. Each Coviself test kit will be provided with all testing materials, instructions to use leaflet and a biohazard bag to safely dispose of after testing. It is available at economical pricing of Rs 250. Last year, Mylab launched the first RTPCR test of India for COVID-19.

    admin Thu, 05/20/2021 - 16:57
  • Opportunity for Pharmacy graduates at School of Tropical Medicine | Salary upto Rs 67,300 pm

    School of Tropical Medicine is one of the seven such Institutions dedicated to research, care and cure of tropical diseases. STM was founded by Sir Leonard Rogers way back in 1914. The corridors of STM had regular footfall of eminent researchers like Leonard Rogers, Ronald Ross, R Knowels, UN Brahmachari, JB Chatterjee, RN Chopra and many others. The foundation stone of the School of Tropical Medicine was laid by the Governor. Lord Carmichael in the year 1914 on 24th February at the initiative of Sir Leonard Rogers.

    admin Wed, 05/19/2021 - 17:37
  • Recruitment for Pharmacists for COVID-19 Vaccine Clinical Trial Project

    School of Tropical Medicine is one of the seven such Institutions dedicated to research, care and cure of tropical diseases. STM was founded by Sir Leonard Rogers way back in 1914. The corridors of STM had regular footfall of eminent researchers like Leonard Rogers, Ronald Ross, R Knowels, UN Brahmachari, JB Chatterjee, RN Chopra and many others. The foundation stone of the School of Tropical Medicine was laid by the Governor. Lord Carmichael in the year 1914 on 24th February at the initiative of Sir Leonard Rogers.

    admin Tue, 05/18/2021 - 16:55
  • Shilpa Medicare Limited ties up with Dr. Reddys Laboratories Limited for production of Sputnik V vaccine

    Shilpa Biologicals Private Limited, SBPL, has entered into a 3 year DefInitive Agreement with Dr. Reddys Laboratories Limited, DRL, for production supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka.

  • Sun Pharma to Make Eli Lillys Baricitinib Drug in India

    Sun Pharma has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company Lilly for expanding access to Lillys drug, baricitinib in India. Sun Pharma will manufacture and distribute the drug in India.

  • U.S. authorises emergency use of Pfizer COVID-19 vaccine for children

    U.S. Food and Drug Administration, FDA, has expanded the Emergency Use Authorization, EUA, for Pfizer COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in the U.S. for use in this age group.

  • DCGI approves 2-DG medicine for moderate to severe COVID-19 cases

    The Drugs Controller General of India, DCGI, has given permission for the emergency use of 2 deoxyD-glucose, 2-DG medicine as an adjunct therapy in moderate to severe Covid-19 cases.

    An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad.

    admin Sat, 05/08/2021 - 16:06
  • CoVID-19 Project Recruitment at Institute of Life Sciences

    Institute of Life Sciences Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications from Indian Nationals to join in the following positions coterminous with the project duration.

    Project title : Anti-viral screening platform for viral diseases : with special reference to COVID-19.

  • Job for Pharmacists (18 Posts) at Covid 19 Hospitals

    Ballari Covid 19 Hospitals notification for Staff Nurse, Group D, Medical Officer, Pharmacist.

    Post : Pharmacist

    No of Posts : 18
    Qualification : D.Pharm
    Age Limit : upper age limit is 38 years
    Salary : Rs.22000/-

  • NATCO receives Emergency Use approval for Baricitinib tablets for Covid-19 treatment

    Natco Pharma Limited has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (CDSCO) in India. Baricitinib in combination with Remdesivir, is used for treatment of COVID-19 positive patients.

Subscribe to COVID-19

Search this website